Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9312048 | Urology | 2005 | 5 Pages |
Abstract
HER2 overexpression and HER2 gene amplification were infrequent in our series. Thus, only a small number of patients with upper urinary tract TCC might benefit from HER2-targeted (Herceptin) cancer therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Cord Langner, Christof Gross, Peter Rehak, Manfred Ratschek, Josef Rüschoff, Richard Zigeuner,